Q4 Results

Shares of the third-largest U.S. lender were last up 5 per cent in premarket trading on Wednesday after Citigroup said its board has authorized a new share repurchase program

Profit rose to $4.11 billion, or $11.95 per diluted share, for the three months ended Dec. 31, compared with $2.01 billion, or $5.48 per diluted share, a year ago

Samsung's earnings were dented by rising research and development costs and the ramp-up of manufacturing capacity for advanced chips

Robust AI server demand led to strong revenue growth for its cloud and networking products division, said Foxconn, whose customers include AI chip firm Nvidia

Procter & Gamble Hygiene and Health Care Ltd (PGHH) on Wednesday reported 46.40 per cent decline in profit after tax at Rs 81.06 crore for June quarter 2024 on account of increased spending. The company, which follows July-June financial year, had reported a profit after tax of Rs 151.24 crore in the corresponding quarter of the previous fiscal. However, PGHH's revenue from operations was at 931.75 crore as against Rs 852.53 crore a year ago. "PAT for the quarter was Rs 81 crore, with an increase in spending for demand generation to support innovation in healthcare and feminine care," said an earning statement from PGHH. Total expense was at Rs 826.78 crore, up 26 per cent year-on-year. Total income of the Proctor & Gamble entity, which has a portfolio of Vicks in healthcare and Whisper in feminine care, was up 8.86 per cent to Rs 939.06 crore. For the full year, PGHH's profit after tax was flat at Rs 675.02 crore as against Rs 678.14 crore in the previous year. "Reported PAT .

The electric vehicle giant won't unveil a highly anticipated robotaxi until Oct. 10 - and that will only be a prototype

SpiceJet shares: SpiceJet airline reported a standalone net profit of Rs 119 crore in Q4FY24

Budget carrier SpiceJet on Monday reported a six-fold jump in its standalone profit to Rs 119 crore for the January-March quarter of 2023-24 over Rs 16.85 crore profit in the corresponding quarter of the previous year. Revenue from operations during the quarter under review, however, declined 20 per cent to Rs 1,719.37 crore from Rs 2,144.85 crore in the fourth quarter of the financial year ended March 31, 2023, according to a regulatory filing. For the full fiscal 2023-24, the airline posted a loss of Rs 409.43 crore against a loss of Rs 1503 crore in FY 23, as per the filing. For the December quarter, SpiceJet reported a loss at Rs 409.43 crore as against a profit of Rs 106.82 crore in FY23, it stated. "We announce a strong financial performance in Q4 FY2024, with net profit surging sixfold to Rs 119 crore compared to the same quarter last year. The results reflect our relentless efforts to enhance operational efficiency and our commitment to turning around the company's fortune

The company's revenue performance was broadly in line with a 4.6 per cent growth in revenues brought on by a 4 per cent improvement in volumes and a marginal gain in realisations

Operating margins put the pedal to the metal on corporate earnings, fuelled by sector-wide Ebitda margin gains, driving net profits to victory in five straight quarters

For FY24, its consolidated net profit rose by 23 per cent to Rs 1,974.2 crore from Rs 1,607.5 crore in FY23. Its NII rose by 38 per cent Y-o-Y to Rs 4,153.8 crore in FY24

The surge came on the back of an order win worth Rs 1,002 crore

Companies reported combined net sales of Rs 37.57 trillion in Q4FY24, up from the Rs 35.05 trillion in Q4FY24 and Rs 35.44 trillion in Q3FY24

The brokerage firm MOFSL said the tender pipeline remains robust with strong order flows expected post elections.

Suven Pharmaceuticals on Thursday reported a 58 per cent year-on-year (Y-o-Y) decline in net profit at Rs 62.4 crore, while its revenues reduced by 32 per cent Y-o-Y

Shares of Swan Energy fell 4.9 per cent at Rs 574.75 per share on the BSE in Friday's intraday deals. This came after the company delivered a double digit drop in its net profits

Shares of Bharat Rasayan surged 16.8 per cent at Rs 10,736 per share on the BSE in Friday's intraday trade

Q4FY24 company results: Add-Shop ERetail Ltd, Athena Constructions Ltd, and Panorama Studios International Ltd will release their fourth-quarter report on May 31

Apollo Hospitals on Thursday reported a 76 per cent increase in consolidated net profit to Rs 254 crore for the March quarter. The healthcare major had reported a net profit of Rs 144 crore in the January-March period of the 2022-23 fiscal year. Revenue from operations rose to Rs 4,944 crore for the fourth quarter as compared with Rs 4,302 crore in year-ago period, Apollo Hospitals Enterprise said in a regulatory filing. For the year ended March 31, 2024, the company posted a net profit of Rs 899 crore as compared with Rs 819 crore in FY23. Revenue from operations rose to Rs 19,059 crore last fiscal as against Rs 16,612 crore in FY23. "While Apollo leads the paradigm shift in healthcare focused on prevention of diseases, we are committed to advance our research efforts and leverage cutting-edge, new-age technologies like Al and robotics to enhance patient outcomes," Apollo Hospitals Chairman Prathap C Reddy said. Cancer is one of the company's key focus areas given the increasing

Deepak Fertilisers and Petrochemicals Corporation Ltd has posted 16 per cent decline in consolidated net profit to Rs 214.79 crore for the quarter ended March 2024. Its net profit stood at Rs 254.88 crore in the year-ago period. Total income fell to Rs 2,158.56 crore in the quarter from Rs 2,810.73 crore in the year-ago period, according to a regulatory filing on Wednesday. During 2023-24, the company's net profit declined to Rs 442.51 crore from Rs 1,210.10 crore in the preceding year. Total income fell to Rs 8,798.85 crore from Rs 11,384.71 crore.